基于证据的总结 关于成年结核病患者的药物坚持管理与多维策略和实践框架
Fanghui Xie1,2, Rong Yao1,2, Li Liang1,2
1Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Journal of evaluation in clinical practice
|October 27, 2025
概括
优化成年结核病 (TB) 患者的药物坚持包括以患者为中心的护理,健康教育和直接观察治疗 (DOT). 整合数字工具和社会支持对于有效的结核病管理至关重要.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 基于证据的医学基于证据的医学.
背景情况:
- 药物坚持对于成功结核病 (TB) 治疗结果至关重要.
- 低于最佳的坚持有助于治疗失败,耐药性和疾病传播.
- 需要系统地综合证据,以指导临床实践,管理成年结核病患者的药物坚持.
研究的目的:
- 系统地检索,评估和综合利用的最佳证据,以管理成年结核病患者的药物坚持.
- 为优化临床实践和改善治疗结果提供基于证据的基础.
- 开发一个多维干预框架,用于结核病药物治疗.
主要方法:
- 使用PIPOST模型制定了基于证据的问题,并搜索了19个数据库 (包括BMJ最佳实践,世卫组织,科克伦图书馆) 到2025年3月.
- 包括临床指南,系统审查和手册,用AGREE II,AMSTAR和约翰霍普金斯工具评估质量.
- 通过JBI基于证据的医疗保健中心的等级系统来对提取的证据进行分类,总结和分类.
主要成果:
- 包括 14 篇出版物 (5 篇系统审查,6 篇指南,3 篇手册),提供 25 篇证据.
- 主要证据领域:以患者为中心的护理,健康教育,直接观察治疗 (DOT),数字健康技术,不良药物反应管理和患者的社会支持.
- 高级证据 (一级) 支持以患者为中心的护理,教育,医疗保健和社会支持;4级证据支持药物不良反应管理.
结论:
- 多维干预框架可以系统化成人结核病患者的坚持管理.
- 临床实施需要考虑区域资源,文化背景和个体患者的需求.
- 未来的研究重点包括扩展数字技术,开发不良反应早期预警系统,并探索具有成本效益的干预措施.
相关概念视频
Pulmonary Tuberculosis V
533
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
533
Drug Therapy
239
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
239
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.0K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.0K
Pulmonary Tuberculosis I
822
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
822


